Eaton Vance Management Spectrum Pharmaceuticals Inc Transaction History

Eaton Vance Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $332 - $634	-262 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $4,456 - $7,918	-2,073 Reduced 88.78%	262 $0
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $5,204 - $8,014	1,801 Added 337.27%	2,335 $9,000
Q1 2021 May 17, 2021	BUY	$2.9 - $4.09 $1,548 - $2,184	534 New	534 $2,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.